title: Effect of angiotensin II type 2 receptor-interacting protein on adipose tissue function via modulation of macrophage polarization.
abstract: We demonstrated that angiotensin II type 2 (AT2) receptor-interacting protein (ATIP) 1 ameliorates inflammation-mediated vascular remodeling independent of the AT2 receptor, leading us to explore the possibility of whether ATIP1 could exert anti-inflammatory effects and play a role in other pathophysiological conditions. We examined the possible anti-inflammatory effects of ATIP1 in adipose tissue associated with amelioration of insulin resistance. In mice fed a high-cholesterol diet, adipose tissue macrophage (ATM) infiltration and M1-to-M2 ratio were decreased in ATIP1 transgenic mice (ATIP1-Tg) compared with wild-type mice (WT), with decreased expression of inflammatory cytokines such as tumor necrosis factor-α and monocyte chemoattractant protein-1 in white adipose tissue (WAT), but an increase in interleukin-10, an anti-inflammatory cytokine. Moreover, 2-[(3)H]deoxy-d-glucose (2-[(3)H]DG) uptake was significantly increased in ATIP1-Tg compared with WT. Next, we examined the roles of ATIP1 in BM-derived hematopoietic cells, employing chimeric mice produced by BM transplantation into irradiated type 2 diabetic mice with obesity, KKAy, as recipients. ATM infiltration and M1-to-M2 ratio were decreased in ATIP1 chimera (ATIP1-tg as BM donor), with improvement of insulin-mediated 2-[(3)H]DG uptake and amelioration of inflammation in WAT. Moreover, serum adiponectin concentration in ATIP1 chimera was significantly higher than that in WT chimera (WT as BM donor) and KKAy chimera (KKAy as BM donor). These results indicate that ATIP1 could exert anti-inflammatory effects in adipose tissue via macrophage polarization associated with improvement of insulin resistance, and ATIP1 in hematopoietic cells may contribute to these beneficial effects on adipose tissue functions in type 2 diabetes.
authors.affiliation: Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.
authors.forename: Fei
authors.initials: F
authors.lastname: Jing
authors.forename: Masaki
authors.initials: M
authors.lastname: Mogi
authors.forename: Li-Juan
authors.initials: LJ
authors.lastname: Min
authors.forename: Kousei
authors.initials: K
authors.lastname: Ohshima
authors.forename: Hirotomo
authors.initials: H
authors.lastname: Nakaoka
authors.forename: Kana
authors.initials: K
authors.lastname: Tsukuda
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Wang
authors.forename: Jun
authors.initials: J
authors.lastname: Iwanami
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Horiuchi
mesh_terms: D054392:Adipokines / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism* / Q000473:pathology; D052436:Adipose Tissue, White / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001854:Bone Marrow Cells / Q000378:metabolism; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000473:pathology; D004032:Diet; D005947:Glucose / Q000378:metabolism; D006984:Hypertrophy; D007249:Inflammation / Q000235:genetics / Q000378:metabolism; D018836:Inflammation Mediators / Q000378:metabolism; D008264:Macrophages / Q000276:immunology / Q000378:metabolism*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D054392:Adipokines; D002352:Carrier Proteins; D016207:Cytokines; D018836:Inflammation Mediators; C488664:Mtus1 protein, mouse; D025521:Tumor Suppressor Proteins; D005947:Glucose
references.citation: Cell Metab. 2007 Aug;6(2):96-8
references.pmid: 17681144
references.citation: PPAR Res. 2008;2008:785405
references.pmid: 18509498
references.citation: Lancet. 2005 Sep 24-30;366(9491):1059-62
references.pmid: 16182882
references.citation: Am J Clin Nutr. 2006 Feb;83(2):461S-465S
references.pmid: 16470013
references.citation: Blood. 2011 Sep 1;118(9):2556-66
references.pmid: 21636855
references.citation: Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):685-91
references.pmid: 18239153
references.citation: Expert Opin Ther Targets. 2003 Feb;7(1):35-48
references.pmid: 12556201
references.citation: Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):57-64
references.pmid: 15539617
references.citation: Nature. 2006 Dec 14;444(7121):860-7
references.pmid: 17167474
references.citation: J Leukoc Biol. 2005 Mar;77(3):321-7
references.pmid: 15591125
references.citation: Genes Dev. 2000 Apr 15;14(8):963-80
references.pmid: 10783168
references.citation: FASEB J. 2003 Jun;17(9):1180-2
references.pmid: 12692079
references.citation: Int J Cancer. 2007 Feb 1;120(3):702-13
references.pmid: 17096328
references.citation: Am J Physiol. 1991 Sep;261(3 Pt 1):E298-303
references.pmid: 1887876
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040-4
references.pmid: 8265667
references.citation: J Clin Invest. 2007 Jan;117(1):175-84
references.pmid: 17200717
references.citation: Hypertension. 2011 Sep;58(3):404-9
references.pmid: 21768524
references.citation: Cell. 2010 Mar 19;140(6):805-20
references.pmid: 20303872
references.citation: FEBS Lett. 2008 Jan 9;582(1):97-105
references.pmid: 18053812
references.citation: Immunity. 2003 Jul;19(1):71-82
references.pmid: 12871640
references.citation: Hypertension. 1999 Jun;33(6):1414-9
references.pmid: 10373225
references.citation: J Clin Invest. 2006 Jan;116(1):33-5
references.pmid: 16395402
references.citation: J Clin Invest. 2003 Dec;112(12):1821-30
references.pmid: 14679177
references.citation: Nat Rev Immunol. 2003 Jan;3(1):23-35
references.pmid: 12511873
references.citation: J Biol Chem. 1995 Aug 25;270(34):20225-30
references.pmid: 7650042
references.citation: J Clin Invest. 2003 Dec;112(12):1785-8
references.pmid: 14679172
references.citation: J Immunol. 2004 Apr 1;172(7):4410-7
references.pmid: 15034056
references.citation: PLoS One. 2012;7(11):e48387
references.pmid: 23155382
references.citation: Mol Cell Endocrinol. 2006 Jun 27;252(1-2):207-15
references.pmid: 16650523
references.citation: Carcinogenesis. 2007 Jul;28(7):1442-5
references.pmid: 17301065
references.citation: J Immunol. 2011 Dec 1;187(11):5703-11
references.pmid: 22048774
references.citation: Gene. 2006 Oct 1;380(2):127-36
references.pmid: 16887298
references.citation: Circulation. 2010 Jun 8;121(22):2437-45
references.pmid: 20530020
references.citation: Mol Endocrinol. 2007 Feb;21(2):499-511
references.pmid: 17068200
references.citation: Nat Immunol. 2010 Jul;11(7):577-84
references.pmid: 20562844
references.citation: Science. 1993 Jan 1;259(5091):87-91
references.pmid: 7678183
references.citation: Trends Immunol. 2002 Nov;23(11):549-55
references.pmid: 12401408
references.citation: Trends Endocrinol Metab. 2010 Nov;21(11):684-90
references.pmid: 20889352
references.citation: Am J Cardiol. 2002 Jun 15;89(12):1441-3
references.pmid: 12062747
references.citation: Nat Immunol. 2010 Oct;11(10):936-44
references.pmid: 20729857
references.citation: J Biol Chem. 1997 May 2;272(18):11952-8
references.pmid: 9115258
references.citation: Nat Rev Immunol. 2011 Feb;11(2):85-97
references.pmid: 21252989
references.citation: J Clin Invest. 2006 Jul;116(7):1793-801
references.pmid: 16823477
references.citation: Nat Rev Immunol. 2009 Oct;9(10):692-703
references.pmid: 19859064
references.citation: Atherosclerosis. 2010 Dec;213(2):335-44
references.pmid: 20576267
references.citation: J Interferon Cytokine Res. 2009 Jun;29(6):313-26
references.pmid: 19441883
references.citation: J Clin Invest. 2006 Jun;116(6):1494-505
references.pmid: 16691291
references.citation: Diabetes. 2009 Nov;58(11):2574-82
references.pmid: 19690061
references.citation: Endocrinology. 2001 Feb;142(2):608-12
references.pmid: 11159831
references.citation: J Clin Invest. 2012 Mar;122(3):787-95
references.pmid: 22378047
references.citation: J Biol Chem. 2010 Apr 30;285(18):13630-7
references.pmid: 20189995
references.citation: Hypertension. 2006 Jun;47(6):1108-16
references.pmid: 16651465
references.citation: Nat Rev Immunol. 2005 Dec;5(12):953-64
references.pmid: 16322748
references.citation: FASEB J. 2003 Mar;17(3):491-3
references.pmid: 12514109
references.citation: Genes Dev. 2007 Jun 15;21(12):1443-55
references.pmid: 17575046
references.citation: Cell Metab. 2009 Nov;10(5):419-29
references.pmid: 19883619
references.citation: J Biol Chem. 2004 Jul 9;279(28):28989-97
references.pmid: 15123706
references.citation: J Clin Invest. 2003 Dec;112(12):1796-808
references.pmid: 14679176
references.citation: Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1771-6
references.pmid: 22815343
references.citation: Hypertension. 2009 Apr;53(4):688-93
references.pmid: 19221207